Bio-Techne Corp (NASDAQ:TECH)
| 252.43 Delayed Data As of Oct 30 |  -3.26 / -1.27%Today’s Change | 155.17 Today|||52-Week Range 286.68 | +15.00% Year-to-Date |
Latest TECH News | Press Releases
| Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth Oct 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 255.69 |
| Today’s open | 256.51 |
| Day’s range | 250.47 - 256.87 |
| Volume | 11,559 |
| Average volume (3 months) | 162,778 |
| Market cap | $10.3B |
Data as of 4:00pm ET, 10/30/2020
Growth & Valuation
| Earnings growth (last year) | +136.07% |
| Earnings growth (this year) | +20.57% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | +3.46% |
| P/E ratio | 43.3 |
| Price/Sales | 14.09 |
| Price/Book | 7.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NBIXNeurocrine Bioscienc... | -0.35 | -0.35% |
| ZLABZai Lab Ltd | -2.06 | -2.45% |
| CRSPCRISPR Therapeutics ... | -4.63 | -4.81% |
| XLRNAcceleron Pharma Inc | -2.35 | -2.20% |
Data as of 4:00pm ET, 10/30/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | $1.10 |
| Annual revenue (last year) | $738.7M |
| Annual profit (last year) | $229.1M |
| Net profit margin | 31.01% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Minneapolis, Minnesota |
Forecasts
